Hypoxia-Inducible Factor-1α in Vascular Smooth Muscle Regulates Blood Pressure Homeostasis Through a Peroxisome Proliferator-Activated Receptor-γ-Angiotensin II Receptor Type 1 Axis

被引:27
|
作者
Huang, Yan [1 ,2 ]
Di Lorenzo, Annarita [4 ]
Jiang, Weidong [1 ,2 ]
Cantalupo, Anna [4 ,5 ]
Sessa, William C. [2 ,3 ]
Giordano, Frank J. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[4] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
[5] Univ Naples Federico II, Dept Pharmacol, Naples, Italy
基金
美国国家卫生研究院;
关键词
angiotensins; HIF-1; hypertension; muscle; smooth; vascular; PPAR-; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; HYPERTENSION; OXYGEN; HIF-1-ALPHA; RESISTANCE; HEART; ANGIOGENESIS; HYPERTROPHY; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.111.00160
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a major worldwide health issue for which only a small proportion of cases have a known mechanistic pathogenesis. Of the defined causes, none have been directly linked to heightened vasoconstrictor responsiveness, despite the fact that vasomotor tone in resistance vessels is a fundamental determinant of blood pressure. Here, we reported a previously undescribed role for smooth muscle hypoxia-inducible factor-1 (HIF-1) in controlling blood pressure homeostasis. The lack of HIF-1 in smooth muscle caused hypertension in vivo and hyperresponsiveness of resistance vessels to angiotensin II stimulation ex vivo. These data correlated with an increased expression of angiotensin II receptor type I in the vasculature. Specifically, we show that HIF-1, through peroxisome proliferator-activated receptor-, reciprocally defined angiotensin II receptor type I levels in the vessel wall. Indeed, pharmacological blockade of angiotensin II receptor type I by telmisartan abolished the hypertensive phenotype in smooth muscle cell-HIF-1-KO mice. These data revealed a determinant role of a smooth muscle HIF-1/peroxisome proliferator-activated receptor-/angiotensin II receptor type I axis in controlling vasomotor responsiveness and highlighted an important pathway, the alterations of which may be critical in a variety of hypertensive-based clinical settings.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [31] Interference With Peroxisome Proliferator-Activated Receptor-γ in Vascular Smooth Muscle Causes Baroreflex Impairment and Autonomic Dysfunction
    Borges, Giulianna R.
    Morgan, Donald A.
    Ketsawatsomkron, Pimonrat
    Mickle, Aaron D.
    Thompson, Anthony P.
    Cassell, Martin D.
    Mohapatra, Durga P.
    Rahmouni, Kamal
    Sigmund, Curt D.
    HYPERTENSION, 2014, 64 (03) : 590 - +
  • [32] Vascular Smooth Muscle Cell-Selective Peroxisome Proliferator-Activated Receptor-γ Deletion Leads to Hypotension
    Chang, Lin
    Villacorta, Luis
    Zhang, Jifeng
    Garcia-Barrio, Minerva T.
    Yang, Kun
    Hamblin, Milton
    Whitesall, Steven E.
    D'Alecy, Louis G.
    Chen, Y. Eugene
    CIRCULATION, 2009, 119 (16) : 2161 - 2169
  • [33] Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms
    Hamblin, Milton
    Chang, Lin
    Zhang, Hengmin
    Yang, Kun
    Zhang, Jifeng
    Chen, Y. Eugene
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (04) : 984 - 993
  • [34] Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ1 gene expression in human aortic smooth muscle cells
    Fu, MG
    Zhang, JF
    Lin, YM
    Zhu, XJ
    Ehrengruber, MU
    Chen, YQE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) : 26808 - 26814
  • [35] Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis
    Parham, Kate A.
    Zebol, Julia R.
    Tooley, Katie L.
    Sun, Wai Y.
    Moldenhauer, Lachlan M.
    Cockshell, Michaelia P.
    Gliddon, Briony L.
    Moretti, Paul A.
    Tigyi, Gabor
    Pitson, Stuart M.
    Bonder, Claudine S.
    FASEB JOURNAL, 2015, 29 (09): : 3638 - 3653
  • [36] Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade
    Kusunoki, Hiroshi
    Taniyama, Yoshiaki
    Azuma, Junya
    Iekushi, Kazuma
    Sanada, Fumihiro
    Otsu, Rei
    Iwabayashi, Masaaki
    Okayama, Keita
    Rakugi, Hiromi
    Morishita, Ryuichi
    HYPERTENSION, 2012, 59 (02) : 308 - +
  • [37] Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor
    Meyer, Maxime
    Foulquier, Sebastien
    Dupuis, Francois
    Flament, Stephane
    Grimaud, Linda
    Henrion, Daniel
    Lartaud, Isabelle
    Monard, Gerald
    Grillier-Vuissoz, Isabelle
    Boisbrun, Michel
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 158 : 334 - 352
  • [38] Evidence of hypoxia-inducible factor-1 in vascular endothelial and smooth muscle cells
    Schmedtje, JF
    Liu, WL
    Ji, YS
    Thompson, TM
    Runge, MS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) : 687 - 691
  • [39] Peroxisome proliferator-activated receptor-γ coactivator-1α in muscle links metabolism to inflammation
    Handschin, Christoph
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (12) : 1139 - 1143
  • [40] Hypoxia Regulates the Expression of the Neuromedin B Receptor through a Mechanism Dependent on Hypoxia-Inducible Factor-1α
    Park, Hyun-Joo
    Kim, Mi-Kyoung
    Kim, Su-Ryun
    Bae, Soo-Kyung
    Bae, Moon-Kyoung
    PLOS ONE, 2013, 8 (12):